Form4insider filings, from the source

SEC Form 4 · accession 0001104659-15-059968

LIGAND PHARMACEUTICALS INC · LGND

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Aug 12, 2015
Accepted (ET)
Aug 14, 2015 · 12:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000886163

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F3Aug 12, 2015S800$96.4543D971,300IBy Knott Partners, L.P.
Common StockF1,F3Aug 12, 2015S9,875$96.4543D223,486IBy Shoshone Partners, L.P.
Common StockF1,F3Aug 12, 2015S2,600$96.4543D37,996IBy Knott Partners Offshore Master Fund, L.P.
Common StockF1,F3Aug 13, 2015S2,000$96.1957D969,300IBy Knott Partners, L.P.
Common StockF1,F3Aug 13, 2015S27,300$96.1957D196,186IBy Shoshone Partners, L.P.
Common StockF1,F3Aug 13, 2015S7,225$96.1957D30,771IBy Knott Partners Offshore Master Fund, L.P.
Common StockF2,F3holding———1,666IBy Managed Account C
Common Stockholding———70,152D
Common StockF2,F3holding———1,843IBy immediate family member

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses